Chief Medical Officer · SERA PROGNOSTICS, INC. · Class A Common Stock
Side
SELL
Value
$972
Shares
486
Price
$2
Executed
Sep 10, 2026
Disclosed
Sep 11, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Sep 10 executedSep 11, 2026 disclosed
SERA · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+4 / 15
1 prior trade recorded in this security
Frequency & clustering+15 / 15
3 other actors traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Inglis Tiffany Eul Davis filed this Form 4 reporting a open-market sale of SERA on Sep 10, 2026. It became public on Sep 11, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Medical Officer
Inglis Tiffany Eul Daviscik:0002091798
Issuer
SERA PROGNOSTICS, INC.cik:0001534969
Revision history · 0
No field has changed since this record was first ingested.
